KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Leases (2019 - 2025)

Boston Scientific's Leases history spans 7 years, with the latest figure at $465.0 million for Q4 2025.

  • For Q4 2025, Leases rose 3.56% year-over-year to $465.0 million; the TTM value through Dec 2025 reached $465.0 million, up 3.56%, while the annual FY2025 figure was $465.0 million, 3.56% up from the prior year.
  • Leases for Q4 2025 was $465.0 million at Boston Scientific, down from $495.0 million in the prior quarter.
  • Across five years, Leases topped out at $495.0 million in Q3 2025 and bottomed at $386.0 million in Q4 2022.
  • The 5-year median for Leases is $428.0 million (2024), against an average of $430.8 million.
  • The largest annual shift saw Leases surged 33.44% in 2021 before it dropped 11.26% in 2022.
  • A 5-year view of Leases shows it stood at $435.0 million in 2021, then fell by 11.26% to $386.0 million in 2022, then increased by 13.73% to $439.0 million in 2023, then rose by 2.28% to $449.0 million in 2024, then increased by 3.56% to $465.0 million in 2025.
  • Per Business Quant, the three most recent readings for BSX's Leases are $465.0 million (Q4 2025), $495.0 million (Q3 2025), and $492.0 million (Q2 2025).